Categories: News

Cecelia Health CEO Named Leading Health Transformer in Healthcare & Technology

NEW YORK, March 26, 2019 /PRNewswire/ — David Weingard, CEO of Cecelia Health, a leading technology-enabled diabetes and related chronic disease management company based in New York City, has been recognized in MM&M’s 2019 class of Top 40 Healthcare Transformers.

Since 2015, MM&M has shared their honor roll of visionaries, gurus, self-starters, operators, and executives who are bravely working to revolutionize the nation’s $3 trillion healthcare industry. The 2019 Healthcare Transformers Class is among the most distinguished, with inductees who hold key posts in the most prominent health industry corporations today including Pfizer, Glaxo Smith Kline, Bayer, Sanofi and more. This class also features impressive leaders from the FDA and Amazon to round out the list of those whose contributions drive innovation in healthcare via technology.

“Being recognized by MM&M as a Top 40 Healthcare Transformer with this illustrious class of professionals and organizations who are defining the future of the healthcare landscape in the Unites States, is an incredible honor for me and the entire Cecelia Health team,” states Cecelia Health CEO, David Weingard. “Cecelia Health’s mission is to transform the lives of the millions of people living with diabetes and related chronic conditions. This award reinforces our mission to expand beyond the hundreds of thousands of lives we have already positively impacted, and further extend the technology platform we use to provide personalized coaching to the patients of the pharmaceutical, device, health plans and self-insured employers that we serve.”

“This year’s class of Transformers reflects the tremendous growth we’re seeing in MedTech, as well as a more holistic approach to health in general,” said Stephen Madden, MM&M’s editor-in-chief. “And as always, it’s pretty amazing to see how many very smart, creative people are working to help communities manage and improve their health.”

The MM&M Top 40 Healthcare Transformers Awards are judged with the utmost independence and authority, using an esteemed panel of leaders and thinkers representing a wide variety of disciplines and backgrounds within the healthcare marketing community. Inductees will be celebrated at an awards reception in New York City on May 7th.

About Cecelia Health
Cecelia Health’s mission is to positively transform the lives of people living with diabetes and related chronic disease states. Cecelia Health’s Certified Diabetes Educator (CDE) and other expert clinicians use Cecelia Health’s proprietary technology-enabled personalized coaching solution to optimize health outcomes at a low cost per patient and provide unique data-driven insights to health plans and ACOs seeking to improve quality measures, and pharmaceutical and medical device companies seeking to improve adherence. Cecelia Health has also engaged in numerous joint initiatives with the Juvenile Diabetes Research Foundation, American Diabetes Association, the Diabetes Research Institute, the American Association of Diabetes Educators, the Jaeb Center for Health Research and the Helmsley Charitable Trust.

View original content to download multimedia:http://www.prnewswire.com/news-releases/cecelia-health-ceo-named-leading-health-transformer-in-healthcare–technology-300818042.html

SOURCE Cecelia Health

user

Recent Posts

Daily Fit Notes Rolls Out Affordable Fitness Solutions for the Modern Lifestyle

Daily Fit Notes, founded by Justin Brey in New York, launches a text-based subscription fitness…

15 hours ago

WillowWood Rebrand by DD.NYC Wins Gold Anthem Award for Product and Innovation in 2024 Rebrand

MT. STERLING, Ohio, Dec. 20, 2024 /PRNewswire/ -- WillowWood, a global leader in prosthetic solutions,…

1 day ago

Quantum Biopharma Announces Closing of Second Tranche

TORONTO, ON / ACCESSWIRE / December 20, 2024 / Quantum BioPharma Ltd. (NASDAQ:QNTM)(CSE:QNTM)(FRA:0K91) ("Quantum BioPharma"…

1 day ago

Glow Lifetech Announces Completion of Final Payment under Swiss Pharma Share Exchange Agreement and Debt Settlement

Toronto, Ontario--(Newsfile Corp. - December 20, 2024) - Glow Lifetech Corp. (CSE: GLOW) (OTC Pink:…

1 day ago

Bloom Burton & Co. Inc. Announces Changes to Holdings in Satellos Bioscience Inc.

Toronto, Ontario--(Newsfile Corp. - December 20, 2024) - Bloom Burton & Co. Inc. (Bloom Burton)…

1 day ago